Empowers its European Staff to Capture Advanced Medical Knowledge, Promotes Innovation in Technology, and Enhances the Quality and Service Standard of the Refractive Field EuroEyes International Eye Clinic Limited (“EuroEyes”…
Indonesia now market leader in IP protection in South East Asia boosting growth legitimate services A new study of the online content viewing behaviour of Indonesian consumers, has found a…
Samtrade FX today announced that it has appointed Vic Tham, a veteran of the banking and finance industry, as its Global Chief Risk and Compliance Officer (“GCRCO”). Tham, 57, brings…
In light of the COVID-19 situation, this year’s HKTDC Entrepreneur Day (E-Day) has undergone a transformation in terms of format and content, with a series of seminars being broadcast live…
Sino-Entertainment Technology Holdings Limited (“Sino-Entertainment Technology Holdings” or the “Company”, together with its subsidiaries, collectively referred as the “Group”) is pleased to announce that the shares of Sino-Entertainment Technology Holdings…
On July 12, BYD announced the official launch of its Han EV series, the brand’s long-awaited flagship offering for the global mid-to-large luxury sedan market, including three pure electric models…
UNISOC, the world’s leading supplier of core chips for mobile communications and the Internet of Things, launched its new smartwatch platform UNISOC W307. Based on ultra-low-power architecture design, it adopts…
IQOS has been said to mean “I quit ordinary smoking.” From a technical point of view, IQOS heats a cartridge made of tobacco sheet, nicotine compounds and glycerin to generate…
In the wake of the United Nations (UN) release of its 2020 State of Food Security & Nutrition in the World, CropLife Asia has issued a renewed call for the…
Hao Tian Development Group Limited (HKEX Stock Code: 0474, “Hao Tian Development” or “the Group”) a diversified investment holding company, through its subsidiary Aceso Life Sciences Holding Limited (“Aceso”), and…
Nokia (NYSE:NOK) announced today the availability of a software based upgrade that will enable its 4G/LTE radios to be migrated seamlessly to 5G/NR. These features will have a high value…
Dewpoint Therapeutics, the biomolecular condensates company, announced today that it has forged an exclusive collaboration agreement with Merck (NYSE:MRK), known as MSD outside the United States and Canada, to apply…
Nexi has become the first payment provider to acquire JCB’s online security protocol in Europe, which will strengthen global transactions between Asian-Pacific buyers and luxury Italian e-commerce brands. JCB’s J/Secure™…
July 14, 2020 – Showa Denko (SDK; TSE:4004) has developed wet-resistant heat-conductive aluminum nitride filler to be used as heat-radiation filler for semiconductor devices. SDK has started to offer samples…
Further Miniaturization, Lighter Weight and Higher Output; Applicable to a Wide Range of Electric Vehicles; Aiming for Mass-production in the Next 24 Months Apollo Future Mobility Group Limited (“AFMG”, the…
Accointing Services AG is offering a free crypto tax package for its users ACCOINTING, a crypto tax, and portfolio tracking platform, has launched a free crypto tax solution that allows…
As announced on May 12, Chinese fabless semiconductor company UNISOC increased capital by CNY 5 billion (USD 715 million) to complete its equity restructuring. The IPO process is now on…
The leading Asia-Pacific biotech specialist CRO Novotech is again collaborating with the prestigious biotech and pharma news platform Endpoints News. This webinar focusses on how to advance oncology clinical trials…
亞太地區領先的生物技術委託研究機構CRO Novotech再次與享有盛譽的生物技術和製藥新聞平台Endpoints News合作。本次網絡研討會的主旨是探討如何進一步推進亞太地區的腫瘤臨床試驗，目前亞太地區已經吸引了多達10000項腫瘤學相關研究（GlobalData）。 本次網絡研討會將由Endpoints News出版人Arsalan Arif主持。與會者將包括亞太地區的領先專家和美國生物技術申辦方。 網絡研討會標題：進一步推進亞太地區的腫瘤學研究 播出時間 ：美國東部時間7月14日下午2點 點擊這裡註冊 https://www2.novotech-cro.com/l/223242/2020-06-30/mttpv 目前，亞太地區正在進行、或計劃進行的腫瘤學臨床試驗約有1萬項，2019年在全球範圍內大約50%行業申辦的腫瘤學試驗涵蓋了亞太地區（GlobalData）。 於此同時，自2017年至2019年，業內在亞太地區申辦的腫瘤學臨床試驗啟動數量年均增長超過10%（GlobalData）。 而Novotech則已完成200多項腫瘤學試驗。 Novotech認為： “越來越多的生物技術公司正在考慮在亞太地區大力開展腫瘤學臨床試驗。雖然澳大利亞和新西蘭是開展早期階段試驗的首選地點，但申辦方現已將目光投向亞洲，致力於開展大型後期臨床研究。此外，臨床試驗往往是亞洲患者獲得新的腫瘤治療方法的唯一渠道，最終可顯著提高患者的招募率。” 網絡研討會還將涵蓋： – 全球和亞太地區腫瘤臨床試驗的最新研究和趨勢 – 與其他地區相比，亞洲腫瘤臨床研究機構受COVID-19危機影響較小的原因 – 生物技術公司在亞太地區研究中心開展腫瘤學試驗的益處 – 申辦方和研究人員的反饋 Novotech在主要的亞太國家/地區均設有本地團隊，並剛剛與該地區領先的醫療機構簽署了第30個合作夥伴協議，該計劃使Novotech的客戶能夠與頂尖的科研人員、研究者、學術界領袖等通力合作、共創輝煌。 關於 Novotech – https://novotech-cro.com…
亚太地区领先的生物技术委托研究机构CRO Novotech再次与享有盛誉的生物技术和制药新闻平台Endpoints News合作。本次网络研讨会的主旨是探讨如何进一步推进亚太地区的肿瘤临床试验，目前亚太地区已经吸引了多达10000项肿瘤学相关研究（GlobalData）。 本次网络研讨会将由Endpoints News出版人Arsalan Arif主持。与会者将包括亚太地区的领先专家和美国生物技术申办方。 网络研讨会标题：进一步推进亚太地区的肿瘤学研究 播出时间 ：美国东部时间7月14日下午2点 点击这里注册 https://www2.novotech-cro.com/l/223242/2020-06-30/mttpv 目前，亚太地区正在进行、或计划进行的肿瘤学临床试验约有1万项，2019年在全球范围内大约50%行业申办的肿瘤学试验涵盖了亚太地区（GlobalData）。 于此同时，自2017年至2019年，业内在亚太地区申办的肿瘤学临床试验启动数量年均增长超过10%（GlobalData）。 而Novotech则已完成200多项肿瘤学试验。 Novotech认为： “越来越多的生物技术公司正在考虑在亚太地区大力开展肿瘤学临床试验。虽然澳大利亚和新西兰是开展早期阶段试验的首选地点，但申办方现已将目光投向亚洲，致力于开展大型后期临床研究。此外，临床试验往往是亚洲患者获得新的肿瘤治疗方法的唯一渠道，最终可显著提高患者的招募率。” 网络研讨会还将涵盖： – 全球和亚太地区肿瘤临床试验的最新研究和趋势 – 与其他地区相比，亚洲肿瘤临床研究机构受COVID-19危机影响较小的原因 – 生物技术公司在亚太地区研究中心开展肿瘤学试验的益处 – 申办方和研究人员的反馈 Novotech在主要的亚太国家/地区均设有本地团队，并刚刚与该地区领先的医疗机构签署了第30个合作伙伴协议，该计划使Novotech的客户能够与顶尖的科研人员、研究者、学术界领袖等通力合作、共创辉煌。 关于 Novotech – https://novotech-cro.com…
